Drug Shortage Report for SUBLOCADE
Report ID | 123466 |
Drug Identification Number | 02483092 |
Brand name | SUBLOCADE |
Common or Proper name | Buprenorphine extended release injection |
Company Name | INDIVIOR UK LIMITED |
Market Status | MARKETED |
Active Ingredient(s) | BUPRENORPHINE |
Strength(s) | 300MG |
Dosage form(s) | SOLUTION (EXTENDED RELEASE) |
Route of administration | SUBCUTANEOUS SUBCUTANEOUS |
Packaging size | 1 syringe/pouch |
ATC code | N07BC |
ATC description | |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | 2020-09-01 |
Actual start date | 2020-09-01 |
Estimated end date | 2021-01-31 |
Actual end date | 2021-01-26 |
Shortage status | Resolved |
Updated date | 2021-01-27 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | THE CHAPLEO BUILDING, HENRY BOOT WAY HULL, -- UNITED KINGDOM HU4 7DY |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v1 | 2020-09-01 | English | Compare |
v2 | 2020-09-01 | French | Compare |
v3 | 2020-09-02 | English | Compare |
v4 | 2020-12-14 | English | Compare |
v5 | 2020-12-14 | French | Compare |
v6 | 2021-01-26 | English | Compare |
v7 | 2021-01-26 | English | Compare |
v8 | 2021-01-26 | French | Compare |
v9 | 2021-01-27 | English | Compare |
Showing 1 to 9 of 9